RITUXAN – rituximab 10 mg/mL concentrate,intravenous

Genentech Inc

pemphigus vulgaris; small lymphocytic lymphoma; idiopathic thrombocytopenic purpura; progressive chronic lymphocytic leukemia; granulomatosis with polyangiitis; CD20 positive non-Hodgkin’s lymphoma; microscopic polyangiitis; rheumatoid arthritis; follicular lymphoma; diffuse large B-cell lymphoma; Waldenstrom’s macroglobulinemia; Burkitt’s lymphoma; myasthenia gravis; relapse or refractory non-Hodgkin’s lymphoma; mantle cell lymphoma; chronic lymphocytic leukemia; thrombotic thrombocytopenic purpura

Fridge (2-8°C)